These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1086110)

  • 1. [Von Willebrand-Jürgens syndrome with a variant of factor VIII-associated antigen].
    Böttcher D; Hasler K; Sutor AH; Mair D
    Blut; 1976 Jul; 33(1):33-40. PubMed ID: 1086110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR; Coller BS; Sultan Y
    J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.
    Joist JH; Cowan JF; Zimmerman TS
    N Engl J Med; 1978 May; 298(18):988-91. PubMed ID: 306064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII (Willebrand) antigen and ristocetin-Willebrand factor in pigs with von Willebrand's disease.
    Fass DN; Brockway WJ; Owen CA; Bowie EJ
    Thromb Res; 1976 Mar; 8(3):319-27. PubMed ID: 1083569
    [No Abstract]   [Full Text] [Related]  

  • 6. [Spectrum of von Willebrand-Jürgens syndrome. A study on 53 patients].
    Hasler K; Klink I
    Dtsch Med Wochenschr; 1985 Oct; 110(40):1531-4. PubMed ID: 3930195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A variant of the von Willebrand-Jürgens-syndrome with abnormalities of the factor VIII/von Willebrand factor protein (author's transl)].
    Hasler K; Böttcher D; Engelhardt R
    Blut; 1979 Jan; 38(1):25-34. PubMed ID: 310328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of heterozygotes in both parents of homozygous patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Clin Pathol; 1975 Apr; 28(4):309-16. PubMed ID: 805164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired von Willebrand syndrome with inhibitors both to factor VIII clotting activity and ristocetin-induced platelet aggregation.
    Stableforth P; Tamagnini GL; Dormandy KM
    Br J Haematol; 1976 Aug; 33(4):565-73. PubMed ID: 1087568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor.
    Mohri H; Noguchi T; Kodama F; Itoh A; Ohkubo T
    Am J Clin Pathol; 1987 May; 87(5):663-8. PubMed ID: 3107370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willebrand factor and ristocetin. II. Relationship between Willebrand factor, Willebrand antigen and factor VIII activity.
    Meyer D; Jenkins CS; Dreyfus MD; Fressinaud E; Larrieu MJ
    Br J Haematol; 1974 Dec; 28(4):579-99. PubMed ID: 4549013
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterogeneity of von Willebrand's disease: study of 40 Iranian cases.
    Shoa'i I; Lavergne JM; Ardaillou N; Obert B; Ala F; Meyer D
    Br J Haematol; 1977 Sep; 37(1):67-83. PubMed ID: 303911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a qualitative defect in factor-VIII-related antigen in von Willebrand's disease.
    Thomson C; Forbes CD; Prentice CR
    Lancet; 1974 Apr; 1(7858):594-6. PubMed ID: 4132261
    [No Abstract]   [Full Text] [Related]  

  • 16. Acquired von Willebrand syndrome due to an inhibitor specific for von Willebrand factor antigens.
    Lazarchick J; Pappas AA; Kizer J; Hall SA
    Am J Hematol; 1986 Mar; 21(3):305-14. PubMed ID: 3080872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
    Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
    Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-evaluation of plasmas from patients previously diagnosed as having von Willebrand's disease with the factor VIII-related antigen and ristocetin cofactor assay.
    Ness PM; Hymas PG; Perkins HA
    Am J Clin Pathol; 1979 Jan; 71(1):26-30. PubMed ID: 311154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Willebrand-factor activity and antigen in von Willebrand's disease.
    Meyer D; Jenkins CS; Dreyfus M; Larieu MJ
    Lancet; 1974 Mar; 1(7856):512-3. PubMed ID: 4131919
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M; Kimura A; Chiba Y; Yoshida Y
    Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.